By Professor Phillip David Stricker

Journal articles

Emmett L; Yin C; Crumbaker M; Hruby G; Kneebone A; Epstein R; Nguyen Q; Hickey A; Ihsheish N; O'Neill G; Horvath L; Chalasani V; Stricker P; Joshua AM, 2019, 'Rapid modulation of PSMA expression by androgen deprivation: Serial ⁶⁸Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen blockade', Journal of Nuclear Medicine, 60, pp. 950 - 954, http://dx.doi.org/10.2967/jnumed.118.223099

Blazevski A; Scheltema MJ; Yuen B; Masand N; Cusick T; Haynes A; Shnier R; Stricker PD, 2019, 'Diagnostic accuracy of multiparametric magnetic resonance imaging to detect residual prostate cancer following focal therapy with irreversible electroporation', European Urology Supplements, 18, pp. e1850 - e1850, http://dx.doi.org/10.1016/s1569-9056(19)31341-7

Blazevski* A; Scheltema M; Yuen B; Cusick T; Haynes A-M; Stricker P, 2019, 'FR02-12 LAB TO LITHOTOMY - A HISTORY OF IRREVERSIBLE ELECTROPORATION FROM LABORATORY TECHNIQUE TO PROSTATE CANCER TREATMENT', Journal of Urology, 201, http://dx.doi.org/10.1097/01.ju.0000555425.31060.d4

Blazevski* A; Scheltema M; Yuen B; Cusick T; Haynes A-M; Stricker P, 2019, 'MP74-16 DIAGNOSTIC ACCURACY OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING TO DETECT RESIDUAL PROSTATE CANCER FOLLOWING FOCAL THERAPY WITH IRREVERSIBLE ELECTROPORATION', Journal of Urology, 201, http://dx.doi.org/10.1097/01.ju.0000557227.53128.e7

Blazevski A; Scheltema MJS; Yuen B; Cusick T; Masand N; Haynes A; Stricker PD, 2019, 'Salvage irreversible electroporation for locally recurrent prostate cancer after radiotherapy – oncologic and functional outcomes', European Urology Supplements, 18, pp. e1049 - e1049, http://dx.doi.org/10.1016/s1569-9056(19)30758-4

Blazevski A; Scheltema M; Yuen B; Masand N; Cusick T; Haynes A; Stricker P, 2019, 'Update on 12-month biopsy proven oncological and functional outcomes of primary irreversible electroporation for localised prostate cancer', European Urology Supplements, 18, pp. e617 - e617, http://dx.doi.org/10.1016/s1569-9056(19)30456-7

Jaratlerdsiri W; Chan EKF; Gong T; Petersen DC; Kalsbeek AMF; Venter PA; Stricker PD; Riana Bornman MS; Hayes VM, 2018, 'Whole-genome sequencing reveals elevated tumor mutational burden and initiating driver mutations in African men with treatment-naïve, high-risk prostate cancer', Cancer Research, 78, pp. 6736 - 6746, http://dx.doi.org/10.1158/0008-5472.CAN-18-0254

Gielchinsky I; Chang J; Cusick T; Delprado W; Nguyen Q; Yuen C; Savdie R; Böhm M; Haynes AM; Scheltema MJ; Stricker PD, 2018, 'Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook', BJU International, 122, pp. 35 - 41, http://dx.doi.org/10.1111/bju.14586

Scheltema MJ; Chang JI; Böhm M; van den Bos W; Blazevski A; Gielchinsky I; Kalsbeek AMF; van Leeuwen PJ; Nguyen TV; de Reijke TM; Siriwardana AR; Thompson JE; de la Rosette JJ; Stricker PD, 2018, 'Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy', World Journal of Urology, 36, pp. 1383 - 1389, http://dx.doi.org/10.1007/s00345-018-2281-z

Algohary A; Viswanath S; Shiradkar R; Ghose S; Pahwa S; Moses D; Jambor I; Shnier R; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Purysko AS; Verma S; Ponsky L; Stricker P; Madabhushi A, 2018, 'Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings', Journal of Magnetic Resonance Imaging, 48, pp. 818 - 828, http://dx.doi.org/10.1002/jmri.25983

Penzias G; Singanamalli A; Elliott R; Gollamudi J; Shih N; Feldman M; Stricker PD; Delprado W; Tiwari S; Böhm M; Haynes AM; Ponsky L; Fu P; Tiwari P; Viswanath S; Madabhushi A, 2018, 'Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings', PLoS ONE, 13, http://dx.doi.org/10.1371/journal.pone.0200730

Thompson JE; Stricker PD, 2018, 'MRI improves active surveillance of prostate cancer however biopsy is still crucial', BJU International, 122, pp. E1 - E2, http://dx.doi.org/10.1111/bju.14424

Nair SS; Luu PL; Qu W; Maddugoda M; Huschtscha L; Reddel R; Chenevix-Trench G; Toso M; Kench JG; Horvath LG; Hayes VM; Stricker PD; Hughes TP; White DL; Rasko JEJ; Wong JJL; Clark SJ, 2018, 'Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten', Epigenetics and Chromatin, 11, http://dx.doi.org/10.1186/s13072-018-0194-0

Pidsley R; Lawrence MG; Zotenko E; Niranjan B; Statham A; Song J; Chabanon RM; Qu W; Wang H; Richards M; Nair SS; Armstrong NJ; Nim HT; Papargiris M; Balanathan P; French H; Peters T; Norden S; Ryan A; Pedersen J; Kench J; Daly RJ; Horvath LG; Stricker P; Frydenberg M; Taylor RA; Stirzaker C; Risbridger GP; Clark SJ, 2018, 'Enduring epigenetic landmarks define the cancer microenvironment', Genome Research, 28, pp. 625 - 638, http://dx.doi.org/10.1101/gr.229070.117

van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD, 2018, 'Focal irreversible electroporation as primary treatment for localized prostate cancer', BJU International, 121, pp. 716 - 724, http://dx.doi.org/10.1111/bju.13983

Thompson JE; Egger S; Böhm M; Siriwardana AR; Haynes AM; Matthews J; Scheltema MJ; Stricker PD, 2018, 'Superior Biochemical Recurrence and Long-term Quality-of-life Outcomes Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve—Updated Analysis of a Prospective Single-surgeon Cohort of 2206 Consecutive Cases', European Urology, 73, pp. 664 - 671, http://dx.doi.org/10.1016/j.eururo.2017.11.035

Lin HM; Lee BY; Castillo L; Spielman C; Grogan J; Yeung NK; Kench JG; Stricker PD; Haynes AM; Centenera MM; Butler LM; Shreeve SM; Horvath LG; Daly RJ, 2018, 'Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer', Prostate, 78, pp. 308 - 317, http://dx.doi.org/10.1002/pros.23476

Kalsbeek AMF; Chan EKF; Grogan J; Petersen DC; Jaratlerdsiri W; Gupta R; Lyons RJ; Haynes AM; Horvath LG; Kench JG; Stricker PD; Hayes VM, 2018, 'Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer', Prostate, 78, pp. 25 - 31, http://dx.doi.org/10.1002/pros.23440

Thompson J; Stricker P, 2018, 'Imaging: MRI improves cost and accuracy of prostate cancer biopsy', Nature Reviews Urology, 15, pp. 6 - 8, http://dx.doi.org/10.1038/nrurol.2017.185

Gielchinsky I; Scheltema MJ; Cusick T; Chang J; Shnier R; Moses D; Delprado W; Nguyen Q; Yuen C; Haynes AM; Stricker PD, 2018, 'Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50', Research and Reports in Urology, 10, pp. 145 - 150, http://dx.doi.org/10.2147/RRU.S169017

Roach PJ; Francis R; Emmett L; Hsiao E; Kneebone A; Hruby G; Eade T; Nguyen QA; Thompson BD; Cusick T; McCarthy M; Tang C; Ho B; Stricker PD; Scott AM, 2018, 'The impact of ⁶⁸ Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study', Journal of Nuclear Medicine, 59, pp. 82 - 88, http://dx.doi.org/10.2967/jnumed.117.197160

Emmett L; Nandurkar R; Van Leeuwen P; Woo H; Kooner R; Ende D; O’Neill G; Yuen C; Ho B; Nguyen Q; Hickey A; Stricker P, 2018, 'Staging with Ga-68 HBED-CC-Glu-NH-CO-NH-Lys (Ahx) PSMA-11 PET CT (PSMA) prior to radical prostatectomy has high predictive value in assessing biochemical response to surgery', European Urology Supplements, 17, pp. e1903 - e1903, http://dx.doi.org/10.1016/s1569-9056(18)32310-8

van Leeuwen PJ; Hayen A; Thompson JE; Moses D; Shnier R; Böhm M; Abuodha M; Haynes AM; Ting F; Barentsz J; Roobol M; Vass J; Rasiah K; Delprado W; Stricker PD, 2017, 'A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy', BJU International, 120, pp. 774 - 781, http://dx.doi.org/10.1111/bju.13814

Emmett L; Van Leeuwen PJ; Nandurkar R; Scheltema MJ; Cusick T; Hruby G; Kneebone A; Eade T; Fogarty G; Jagavkar R; Nguyen Q; Ho B; Joshua AM; Stricker P, 2017, 'Treatment outcomes from ⁶⁸Ga-PSMA PET/CT-informed salvage radiation treatment in men with rising PSA after radical prostatectomy: Prognostic value of a negative PSMA PET', Journal of Nuclear Medicine, 58, pp. 1972 - 1976, http://dx.doi.org/10.2967/jnumed.117.196683

Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD, 2017, 'Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer', BJU International, 120, pp. 51 - 58, http://dx.doi.org/10.1111/bju.13991

Siriwardana A; Thompson J; van Leeuwen PJ; Doig S; Kalsbeek A; Emmett L; Delprado W; Wong D; Samaratunga H; Haynes AM; Coughlin G; Stricker P, 2017, 'Initial multicentre experience of ⁶⁸gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited', BJU International, 120, pp. 673 - 681, http://dx.doi.org/10.1111/bju.13919

Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG, 2017, 'Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up', BJU International, 120, pp. 651 - 658, http://dx.doi.org/10.1111/bju.13857

Zhang AY; Grogan JS; Mahon KL; Rasiah K; Sved P; Eisinger DR; Boulas J; Vasilaris A; Henshall SM; Stricker PD; Kench JG; Horvath LG, 2017, 'A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer', Annals of Oncology, 28, pp. 1903 - 1909, http://dx.doi.org/10.1093/annonc/mdx247

Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A, 2017, 'Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study', Journal of Magnetic Resonance Imaging, 46, pp. 184 - 193, http://dx.doi.org/10.1002/jmri.25562

Siriwardana A; Thompson J; Stricker P, 2017, 'Personalising prostate cancer care Part 2. Current treatment options', Medicine Today, 18, pp. 28 - 33

Thompson JE; Stricker PD, 2017, 'Diagnostic accuracy of multi-parametric MRI and transrectal ultrasound-guided biopsy in prostate cancer', The Lancet, 389, pp. 767 - 768, http://dx.doi.org/10.1016/S0140-6736(17)30121-6

Rusu M; Purysko AS; Verma S; Kiechle J; Gollamudi J; Ghose S; Herrmann K; Gulani V; Paspulati R; Ponsky L; Böhm M; Haynes AM; Moses D; Shnier R; Delprado W; Thompson J; Stricker P; Madabhushi A, 2017, 'Computational imaging reveals shape differences between normal and malignant prostates on MRI', Scientific Reports, 7, http://dx.doi.org/10.1038/srep41261

Siriwardana A; Thompson J; Stricker P, 2017, 'Personalising prostate cancer care Part 1. Advances in diagnosis', Medicine Today, 18, pp. 29 - 32

van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD, 2017, 'Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer', BJU International, 119, pp. 209 - 215, http://dx.doi.org/10.1111/bju.13540

Siriwardana A; Van Den Bos W; Thompson J; Shnier R; Stricker PD, 2017, 'The role of MRI in prostate cancer: A changing paradigm', Medicine Today, 18, pp. 44 - 46

Bayliss DR; Duff J; Stricker P; Walker K, 2017, 'Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.', Urol Nurs, 37, pp. 15 - 22, https://www.ncbi.nlm.nih.gov/pubmed/29240360

Kalsbeek AMF; Chan EFK; Grogan J; Petersen DC; Jaratlerdsiri W; Gupta R; Lyons RJ; Haynes A-M; Horvath LG; Kench JG; Stricker PD; Hayes VM, 2017, 'Mitochondrial genome content is decreased in prostate cancer overall, but increased in high grade cancer', Pathology, 49, pp. S104 - S105, http://dx.doi.org/10.1016/j.pathol.2016.12.300

Kalsbeek A; Chan E; Grogan J; Petersen D; Jaratlerdsiri W; Gupta R; Lyons R; Haynes A-M; Horvath L; Kench J; Stricker P; Hayes V, 2017, 'MP83-01 HIGH-GRADE PROSTATE CANCER HAS INCREASED MITOCHONDRIAL CONTENT', Journal of Urology, 197, http://dx.doi.org/10.1016/j.juro.2017.02.2569

Bruce HM; Stricker PD; Gupta R; Savdie RR; Haynes AM; Mahon KL; Lin HM; Kench JG; Horvath LG, 2016, 'Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer', Prostate, 76, pp. 1491 - 1500, http://dx.doi.org/10.1002/pros.23233

Penzias G; Janowczyk A; Singanamalli A; Rusu M; Shih N; Feldman M; Stricker PD; Delprado W; Tiwari S; Böhm M; Haynes AM; Ponsky L; Viswanath S; Madabhushi A, 2016, 'AutoStitcher: An Automated Program for Efficient and Robust Reconstruction of Digitized Whole Histological Sections from Tissue Fragments', Scientific Reports, 6, pp. 29906, http://dx.doi.org/10.1038/srep29906

Bayliss D; Duff J; Stricker P; Walker K, 2016, 'Decision-Making in Prostate Cancer: Active Surveillance Over Other Treatment Options', Urologic nursing, 36, pp. 141 - 149, http://dx.doi.org/10.7257/1053-816X.2016.36.3.141

Galvão DA; Taaffe DR; Spry N; Gardiner RA; Taylor R; Risbridger GP; Frydenberg M; Hill M; Chambers SK; Stricker P; Shannon T; Hayne D; Zopf E; Newton RU, 2016, 'Enhancing active surveillance of prostate cancer: The potential of exercise medicine', Nature Reviews Urology, 13, pp. 258 - 265, http://dx.doi.org/10.1038/nrurol.2016.46

Thompson JE; Van Leeuwen PJ; Moses D; Shnier R; Brenner P; Delprado W; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD, 2016, 'The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer', Journal of Urology, 195, pp. 1428 - 1435, http://dx.doi.org/10.1016/j.juro.2015.10.140

Ting F; Van Leeuwen PJ; Stricker PD, 2016, 'Step-by-Step Technique for Irreversible Electroporation of Focal Prostate Cancer: An Instructional Video Guide', Journal of Vascular and Interventional Radiology, 27, pp. 568, http://dx.doi.org/10.1016/j.jvir.2016.01.003

Ting F; Tran M; Böhm M; Siriwardana A; Van Leeuwen PJ; Haynes AM; Delprado W; Shnier R; Stricker PD, 2016, 'Focal irreversible electroporation for prostate cancer: Functional outcomes and short-term oncological control', Prostate Cancer and Prostatic Diseases, 19, pp. 46 - 52, http://dx.doi.org/10.1038/pcan.2015.47

Ting F; Van Leeuwen PJ; Thompson J; Shnier R; Moses D; Delprado W; Stricker PD, 2016, 'Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy', Prostate Cancer, 2016, pp. 3794738, http://dx.doi.org/10.1155/2016/3794738

Tran M; Thompson J; Böhm M; Pulbrook M; Moses D; Shnier R; Brenner P; Delprado W; Haynes AM; Savdie R; Stricker PD, 2016, 'Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy', BJU International, 117, pp. 48 - 54, http://dx.doi.org/10.1111/bju.13090

Kalsbeek AMF; Chan EFK; Grogan J; Petersen DC; Jaratlerdsiri W; Gupta R; Lyons RJ; Haynes AM; Horvath LG; Kench JG; Stricker PD; Hayes VM, 2016, 'Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer', Aging, 8, pp. 2702 - 2712, http://dx.doi.org/10.18632/aging.101044

Van Leeuwen PJ; Siriwardana A; Roobol M; Ting F; Nieboer D; Thompson J; Delprado W; Haynes AM; Brenner P; Stricker P, 2016, 'Predicting low-risk prostate cancer from transperineal saturation biopsies', Prostate Cancer, 2016, pp. 7105678, http://dx.doi.org/10.1155/2016/7105678

Van Leeuwen PJ; Emmett L; Hruby G; Kneebone A; Stricker P, 2016, '548 68Ga-PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment', European Urology Supplements, 15, pp. e548 - e548, http://dx.doi.org/10.1016/s1569-9056(16)60550-x

Back to profile page